NDSN vs RPRX · P/E 31, rev $817.7M vs P/E 15, rev $1.30B
Nordson Corporation (NDSN) versus Royalty Pharma Plc (RPRX) — a side-by-side from cached financials, not a winner call.
Nordson Corporation (NDSN) is a specialty industrial machinery company listed on NASDAQ.
Royalty Pharma Plc (RPRX) is a biotechnology company listed on US.
Latest reported NDSN revenue for 2026-07-31 was $817.7M. Net income was $152.8M. Revenue was down 42.0% from 2026-04-30 to 2026-07-31. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
Latest reported RPRX revenue for 2026-06-30 was $1.30B. Net income was $312.6M. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
NDSN currently screens at market cap $16.17B and trailing P/E 31.0. RPRX currently screens at market cap $20.45B and trailing P/E 14.8.
Not investment advice. Open the NDSN and RPRX stock pages for the full models.
Not investment advice.